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Abstract

Introduction

The marked radiosensitivity of renal tissue represents a limitation on the total radiotherapeutic dose that
safely can be applied to treatment volumes that include
the kidneys. Radiation nephropathy is characterized by
a progressive reduction in renal hemodynamics associated with a severe anemia. The latter is often normochromic normocytic in character, but can progress to a
microangiopathic hemolytic anemia. The pathogenic
mechanisms responsible for the development of radiation
nephropathy remain ill-defined. Experimental studies
which allow serial determinations of functional, morphologic, and cell kinetic radiation-induced changes indicate
that primarily glomerular but also tubular alterations
occur in the primary stages of radiation nephropathy.
Glomerular capillary endothelial cell loss is seen within
several weeks of irradiation. Remaining endothelial
cells exhibit increased permeability leading to a subendothelial transudate. Mesangiolysis also is observed. In
contrast, podocytes appear to be relatively unaffected at
this stage. The endothelial changes appear to resolve,
but the mesangial lesions progress, with hypercellularity
and/or hypertrophy, increased mesangial matrix, mesangial sclerosis, and ultimately, glomerulosclerosis. These
mesangial changes are similar to those observed in other
chronic glomerulopathies. Dietary protein restriction,
corticosteroids, and ACE-inhibitors all can reduce the
severity of experimental radiation nephropathy.

Since the earliest reports describing the effects of
X-rays on the kidney [12], there have been conflicting
views concerning the relative sensitivity of the organ,
particularly the specific components of the nephron, to
radiation. Some authors considered the kidney to be radioresistant [93, 94], leading to statements such as this
by McQuarrie and Whipple [118]: "We feel confident
that the clinician may use the X-rays over the kidney
areas with confidence that renal tissue is resistant to the
hard Roentgen rays." Others inferred from experimental
observations that patients who had impaired renal function, or whose kidneys were "under special stress",
should not be treated with radiation or should be followed up closely after X-ray exposure [48]. Not until
the excellent experimental studies by Hartman et al. [65,
66], confirmed in a later clinical report [43], was it universally appreciated that renal tissue was radiosensitive.
Indeed, from the standpoint of serious or fatal damage,
the kidneys are probably the most radiosensitive of the
abdominal organs [16].
This marked radiosensitivity frequently limits the
total dose that can be safely applied to treatment volumes in which the kidneys are included. The classic
study of Kunkler et al. [96] defined the clinical radiation
tolerance of the kidney by studying a number of patients
who had received bilateral renal irradiation with 250 kV
X-rays during the treatment of testicular tumors. They
established that a total dose of 23 Gy, given over a 5
week period, carried with it a high risk of renal damage.
More recently, a tolerance dose of some 20 Gy has been
proposed [95]. The recognition of this, and subsequent
improvements in radiotherapeutic practice, have allowed
radiation oncologists to reduce the radiation dose to
which the kidney is exposed during irradiation for malignancies. This has resulted in a low incidence of radiation-induced renal morbidity (radiation nephropathy) in
patients. A review of clinical accounts of renal radiation
injury revealed the existence, by 1964, of only 120 cases
[123]. However, the recent development of total body
irradiation (TBI) for bone marrow ablation, as a prerequisite to hone marrow transplantation (BMT), has led to
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or necrosis, and hyaline material in arterial walls. In
the following years, there were several reports of radiation-induced renal injury (for reviews see [63, 145]), but
it was Luxton [106, 107, 108], who, in a close followup of 58 patients arising from the irradiation study of
Kunkler et al. [96], first classified the lesions into five
categories: acute radiation nephritis, chronic radiation
nephritis, proteinuria, benign hypertension, and malignant hypertension. Since, these "categories" overlap,
individual cases may go through several of these phases
during the course of developing renal damage.

'•'·-~ ,

Acute radiation nephritis (ARN) ARN usually
presents after a latent period of 6-12 months in adults
(so it is not acute in the usual sense), but may develop
earlier in children [209, 210]. The clinical picture is
one of edema, dyspnea, headaches, and moderate hypertension. A normochromic normocytic anemia may develop; in severe cases, a microangiopathic hemolytic
anemia may develop, fragmented red blood cells (schistocytes) may be detectable, and thrombocytopenia and
purpura may arise later. The development of anemia is
indicative of severe later changes and implies a poor
prognosis. The symptoms and physiological alterations
are usually moderate, but may develop into severe malignant hypertension. Of 22 patients developing ARN,
12 died from the effects of renal irradiation; all that
survived for an average of 16 years after radiotherapy
had decreased renal function that progressed to chronic
radiation nephritis.

·.·

....

Figure 1. A nephrectomy specimen in which segmental,
arcuate, and intralobular arteries show occlusive intimal
thickening (arrows - internal elastic lamina) which
caused renovascular hypertension in a 5-year-old, 2
years following intraoperative irradiation (dose unknown) for adrenal neuroblastoma. Elastic van Gieson.
Bar= 50 µm.

Chronic radiation nephritis (CRN) CRN may
evolve from ARN or develop in patients who have had
no previous history of ARN. Although it appeared initially that the prognosis of these latter patients was
better, more prolonged follow-up indicated no significant
difference in the long-term survival of the two groups
[107] . The clinical symptoms of CRN are albuminuria,
hypertension, and a reduction in renal function. Anemia
may develop.

--------------------- - --------------a number of reports of radiation nephropathy in longterm survivors of BMT [9, 14, 29 , 32, 73, 84, 102,
105, 188, 191]. Thus, the risk of radiation nephropathy
remains a limiting factor in clinical radiotherapy.
Clinical Pattern of Radiation-Induced
Damage to the Kidney

Benign hypertension Benign hypertension may develop within 2-5 years of the completion of therapy, and
may persist for several years. Patients exhibit the usual
complications associated with hypertension and may succumb to cardiovascular complications.

Warthin [194] was the first to report autopsy findings in kidneys of 2 leukemic patients who received radiation. He described fatty degeneration, necrosis, and
extensive calcification of renal tubules. However, it appears that these changes were instead those of acute uric
acid nephropathy or the so-called tumor lysis syndrome
[31, 130]. Probably the first accurate description of radiation-induced renal damage in a patient was published
in 1927. Domagk [42] described a 9-year-old girl who
received abdominal irradiation for tuberculous mesenteric lymph nodes; she died 6 months later with symptoms of renal failure. At the time of the autopsy, the
kidneys were small and showed glomerular hyalinization
or thickening of the Bowman's capsule, tubular atrophy

Late malignant hypertension Late malignant hypertension may evolve from ARN or CRN and be associated with radiation nephropathy. It also may develop
after irradiation of one kidney and
be relieved by
removing the irradiated kidney.

can

Proteinuria Proteinuria, either intermittent or permanent, may develop after an average interval of 11
years following radiotherapy. Although renal function
in these patients appears normal , they seem to have an
536
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Figure 2. Renal biopsies from three BMT patients
treated with TBI (12 Gy) and multi-agent chemotherapy.
Each micrograph shows a glomerulus from a different
patient: (A) 14 months postirradiation showing florid expansion of the subendothelial space (arrow) and mesangiolysis (M), Jones methenamine silver; (B) 12 months
postirradiation showing widespread capillary loop reduplication (arrow) and focal thrombosis (curved arrow),
Jones methenamine silver; and (C) 5 months postirradiation showing glomerular capillary loop thrombosis with
mesangial extravasation and fragmentation of red blood
cells, hematoxylin and eosin. Bars
10 µm.

impaired renal reserve and exhibit temporary renal
failure after stress.
Three alternative terms were proposed by Mostofi
[123] who evaluated a number of human cases compiled
from the Armed Forces Institute of Pathology files:
nephroendotheliosis, sclerosing nephrosis, and nephroglomerulosis; these correspond to Luxton's proteinuria,
CRN, and ARN, respectively. However, this terminology has not been widely adopted by workers in the field.
It also should be noted that the term "radiation nephritis"
(ARN and CRN) is a misnomer. There is no acute renal

inflammation observed immediately after irradiation.
Moreover, inflammatory exudate is uncommon in irradiated kidneys. More recently, the term radiation
nephropathy has been used to describe the functional
and pathological changes noted following irradiation of
the kidney [36, 51, 198]. The clinical features of
patients exhibiting radiation nephropathy include a
reduction in renal hemodynamics, an increase in serum
creatinine and BUN, anemia (normochromic, normocytic, or hemolytic), proteinuria, and hypertension.
Functional changes

The early investigations into the effects of radiation
on renal function have been reviewed extensively elsewhere [63, 145] and will not be discussed here. There
have been relatively few detailed clinical reports of the
consequences of radiation on renal function, due to the
practical limitations of a prolonged follow-up of patients.
Avioli et al. [11] specifically addressed the problem of
acute and chronic changes in 10 patients who had histo-

M.E.C. Robbins and S.M. Bonsib

Figure 3. Renal biopsies from two BMT patients obtained 14 and 5 months, respectively, after treatment with total
body irradiation (12 Gy) and multiagent chemotherapy. (A) A glomerular capillary showing subendothelial expansion
and a thin layer of new basement membrane (arrow). (B) A glomerular capillary showing endothelial cell denudation
(arrow), thrombosis, and fragmented red blood cells. Bars = 2 µm.
logically confirmed intra-abdominal and/or retroperitoneal malignancies with no evidence of renal disease.
Standard clinical assays, such as BUN levels, urinalysis,
and IVP examination, showed few changes. However,
more detailed studies showed reductions in glomerular
filtration rate (GFR) and renal blood flow, both during
and after the completion of radiotherapy. Indeed, there
was a progressive decline in GFR up to 12 months after
irradiation. Thus, during the latent period, subtle subclinical alterations in renal function occurred before the
clinical expression of injury. Other studies have confirmed the poor diagnostic value of routine renal function tests. When a more accurate monitoring of the
functional status has been carried out, e.g., using
renography or scintigraphic techniques, similar acute and
long-term changes in renal function have been identified
[11, 40, 88, 89, 103, 142). This radiation-induced
reduction in renal function appears to be progressive in
nature [41). However, there have been reports indicating either some recovery in function or a stabilization of
renal function, albeit at levels significantly lower than
those observed prior to radiation [33).
In contrast to these limited clinical data, there is a
wealth of experimental data on radiation nephropathy.
As observed clinically, initial findings in rodents indicated a latent period of some 6 months before any apparent change in renal function [25, 30, 200]. In contrast, studies using large animals such as the monkey [5,
144, 157), pig [148, 150], and dog [34, 120], have reported pronounced changes in GFR and ERPF within

several weeks of radiation. These observations have
been interpreted to be indicative of species differences in
radiation sensitivity. However, recent studies, using
more sensitive indices of renal function, have shown that
early radiation-induced changes in renal function also are
evident in mice and rats [38, 79, 177). There is some
evidence for an initial hyperemic response [144, 148,
177), also seen clinically [11, 189]. This is followed by
a dose-dependent progressive decline in both GFR and
ERPF, evident within some 6-8 weeks of irradiation.
Minimal levels are observed approximately 12-16 weeks
after irradiation; renal function then might continue to
decline, might plateau, or might show an apparent
recovery in function, depending on the radiation dose
administered. It should be noted that a recovery in GFR
and ERPF might be more apparent than real. Renal
function might increase as a result of cellular hypertrophy rather than as a result of cellular repair or repopulation. The use of functional parameters, such as GFR
and ERPF, that measure the overall functional capacity,
cannot distinguish between these two possibilities. Recent studies in the pig have indicated that the overall
time-sequence of changes in GFR and ERPF observed
following unilateral [148, 149] or bilateral radiation
[150), or radiation of a single hypertrophied kidney
[152], is essentially the same. Indeed, a similar pattern
of response has been seen following renal irradiation in
the monkey [157] and rat [24]. This implies a common
response to radiation, a response which is independent
of any variation in the status of the renal tissue prior to
538
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Figure 4. A renal biopsy from a BMT patient taken 5 months after total body irradiation (12 Gy) and multiagent
chemotherapy. (A) A glomerulus with a large acellular tuft and collapsed capillary loops. Note residual podocytes
(arrow) and adjacent arteriolar thrombosis (curved arrow). Hematoxylin and eosin. Bar = 10 µm. (B) Ultrastructural
examination of a collapsed segment shows absent endothelial cells (arrow) and scant residual mesangial cell processes
(curved arrow). Podocytes remain but have lost their foot processes. Bar = 2 µm.

-----------------------------------------------------------------------irradiation. Thus, it is likely that common pathophysiological mechanisms are involved. What does
differ in the various experimental situations is the
severity of the radiation-induced decline in renal
function, and the degree of improvement seen from
around 16 weeks onwards.
These radiation-induced changes in renal hemodynamics are associated with a severe normochromic normocytic anemia [108, 150]; in some cases, this might
progress to a microangiopathic hemolytic anemia [14,
33, 188]. The severity of the anemia is disproportionate
to the degree of azotemia. Two mechanisms have been
proposed to account for this radiation-induced anemia:
hemolysis, and/or a reduction/inhibition in erythropoietin
(Epo) production. · Down et al. [45] noted a marked
anemia in mice following TBI, with fragmented erythrocytes and reticulolysis. Later studies indicated a reduced
erythrocyte life-span, with no apparent alteration in
erythropoiesis [46]. Similar hemolytic changes have
been seen clinically [14, 33, 188]. The critical site for
initiating a microangiopathic hemolysis is believed to be
the glomerular capillary tufts, which do indeed demonstrate marked disruption following irradiation [36, 51,
210]. In contrast, Luxton [108] stated that the severity

of the anemia observed in radiation nephropathy implied
that irradiation interfered with the production of Epo in
the kidney, a conclusion reached earlier in experimental
studies using the mouse [135, 136] and the dog [53].
Detailed blood analyses performed in the pig [150]
showed that localized irradiation of both kidneys resulted
in a normochromic normocytic anemia. Moreover, a
low absolute reticulocyte count was noted, indicating that
the anemia represented inhibition of erythrocyte production. Low plasma Epo levels have been reported in patients exhibiting anemia following TBI [33]. This reduced production has been interpreted as indicating damage to the juxtaglomerular apparatus [4]. The localiz.ation of these Epo-producing cells has been the focus of
intense investigation. Glomerular [23, 28, 92, 97] and
tubular [98] cells have been reported to be primary sites
of Epo production. More recently, studies using 35 S-labeled antisense RNA probes specific for mRNA coding
for Epo have identified interstitial peritubular cells, predominantly located in the cortical labyrinth, as the site
of Epo synthesis [47]. It is likely that both hemolysis
and a decreased Epo production play a role in the development of a radiation-induced anemia. The importance
of the latter has been demonstrated clinically by the sue539
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cessful treatment of anemia using parenteral Epo [33].
Morphologic Changes

The marked radiosensitivity of the kidneys is now
clearly recognized, and the clinical characteristics of radiation nephropathy have been well described. Studies
of changes in renal morphology, ideally, should help ascertain the cell type(s) at risk and, in conjunction with
the observed functional data, provide a rational basis for
an understanding of both the pathogenesis of radiation
nephropathy and the use of interventional procedures directed at ameliorating the severity of this lesion. Clinical pathological studies have been reported (for review
see [36]) but are limited by the fact that damaged kidneys seldom are evaluated before the pathological process is well advanced, thereby precluding accurate determination of primary structural alterations. Furthermore,
much of the literature is from BMT patients in which
nephrotoxic chemotherapeutic drugs may contribute to
the renal injury. Experimental investigations on the
morphologic changes seen following irradiation have
yielded conflicting results. A number of earlier investigators [124], as well as recent authors [67, 81, 119,
121, 139, 203] have indicated that tubular damage is an
early and prominent morphologic alteration in the irradiated kidney. Other authors have reported that glomerularlesions [35, 62, 64, 75, 76, 109, 110, 111, 129, 154,
159, 176] or vascular changes [115, 162, 193] are primarily evident. This lack of agreement has been ascribed to differences in the doses of radiation used,
physiological status of the kidney at the time of radiation, the amount of kidney exposed, and the interval
from radiation to morphologic evaluation; few serial sacrifice studies have been performed. Although species
differences also have been implicated [124], we are of
the opinion that these are of minimal importance. Another factor is the use of insufficiently sensitive histological methods. Electron microscopy studies may reveal
changes not readily visible at a particular time-point
using conventional light microscopy, and the use of specific stains helps to identify particular renal alterations.

Figure 5. A nephrectomy specimen showing radiation
nephropathy in a 5-year-old child, 2 years after intraoperative irradiation (dose unknown) for neuroblastoma.
Extensive mesangiolysis in one glomerulus (arrow) is
present while the adjacent glomeruli appear largely unaffected. Periodic acid-Schiff. Bar = 10 µm.
al. in 1950 [210]. Although most examples of radiation
nephropathy, when encountered on biopsy or at autopsy,
are complex lesions, involving glomeruli, tubules and
vessels, the glomerular component is generally regarded
as the most important. In rare cases, in which biopsies
have been taken relatively early in the clinical course of
radiation nephropathy, glomerular lesions alone are present, only later to be followed by tubulointerstitial and
finally, vascular alterations [85, 86, 161]. The fine details of radiation nephropathy were first revealed in the
ultrastructural study of Rosen et al. [160]; and confirmed and refined in the subsequent literature [85, 86].
The most characteristic lesion observed in human
radiation nephropathy affects the glomerulus. It is characterized by a spectrum of abnormalities (Figs. 2 and 3)
which range from necrotizing cellular injury with thrombosis, to structural alterations of the mesangial matrix
and capillary loop basement membranes. The walls of
the glomerular capillary loops exhibit a prominent thickening, resulting from endothelial cell swelling and separation of the endothelial cell (EC) from the basement
membrane. Often, it is associated with reduplication of
the basement membrane, resulting in a double contour,

Morphology of human radiation nephropathy

The kidney can be damaged either directly or indirectly during therapeutic irradiation. Indirect injury may
develop in patients receiving unilateral irradiation for an
abdominal tumor (Fig. 1). Progressive myointimal proliferation results in occlusive renal artery stenosis, leading to renovascular hypertension and a small atrophic
kidney [37, 39, 60, 91, 117, 165, 171, 174, 192]. The
hypertension can be cured by unilateral nephrectomy
[39, 165, 174].
The morphologic details of direct radiation injury to
the renal parenchyma were first described by Zuelzer et
540
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Figure 6. Experimental models of radiation nephropathy show the characteristic glomerulai- lesion (compare with
Figure 2) characterized by segmental to global mesangiolysis (M) and subendothelial expansion. (A) Mouse, 15 Gy,
12 months postirradiation (PI), hematoxylin and eosin, bar= 8 µm; (B) rat, 15 Gy, 20 weeks PI, periodic acid-Schiff,
bar = 8 µm; (C) pig, 9.8 Gy, 12 weeks PI, periodic acid-Schiff, bar = 10 µm; (D) monkey, 35 Gy, 24 months PI,
hematoxylin and eosin, bar = 10 µm.

-----------------------------------------------------------------------------------------readily apparent by light microscopy with a silver stain
(Figs. 2A and 2B). In its milder forms, this alteration
may be visible only by electron microscopy (Fig. 3A).
The mesangial areas also show prominent enlargement,
with either an increase in matrix or, more characteristically, with a rarefaction of matrix, a process known as
mesangiolysis (Fig. 2). This process can appear at times
dramatic, with massive aneurysmal expansion of mesangial areas. In addition, confluence of capillary loops or

florid expansion of the subendothelial space of the capillary loops can result in marked compromise of the capillary lumina (Fig. 2A).
Glomerular capillary loop thrombosis and arteriolar
thrombosis also may develop; with extension of the
thrombotic phenomena, red blood cells and red cell fragments are observed in the mesangial areas (Figs. 2C and
3B). Although morphologically acute, this abnormality
is rarely detected before 6-12 months postirradiation.
541
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Figure 7. Glomeruli showing mesangiolysis and massive expansion of the subendothelial space (between arrows and
S) with red blood cell extravasation and compromise of the capillary lumina (C). (A) Mouse, 15 Gy, 12 months PI,
bar = 3 µm; and (B) pig, 9.8 Gy, 12 weeks PI, bar = 4 µm.

--------------------------------------------------------------------------------------Ultrastructural studies show fibrin with very few inflammatory cells (Fig. JB), and necrosis of cellular elements, particularly ECs but also mesangial cells (MCs).
By contrast, podocytes appear to be basically intact, although they show variable effacement of their foot processes. Glomerular sclerosis characterized by mesangial
sclerosis and collapse or obliteration of capillary loops,
often devoid of mesangial and ECs, eventually develops
in irreparably damaged glomeruli (Figs. 4A and 4B).
These various lesions may affect either a portion of the
glomerular tuft or the entire glomerular tuft and might
co-exist within a single glomerulus. Moreover, not all
glomeruli are necessarily affected in a uniform fashion.
A severely damaged glomerulus may be adjacent to an
apparently unaffected glomerulus (Fig. 5).
Alterations of tubules and vessels and corresponding
interstitial changes usually are a prominent finding, particularly since more examples of radiation nephropathy
are encountered in the advanced stage. Atrophy of tubules with thick and wrinkled basement membranes and
adjacent interstitial fibrosis is invariable when renal
insufficiency has developed. Accumulation of intimal
foamy macrophages or intimal thickening due to myointimal cell proliferation can develop in large and medium
sized arteries (Fig. 1). Small arteries and arterioles
might develop either medial hyperplasia or thrombosis

(Fig. 4A) with medial necrosis without a significant inflammatory response. The extent to which these tubular
and vascular lesions represent a direct effect of radiation, as opposed to confounding secondary contributions
from hypertension and glomerulosclerosis, is unclear.

Morphology of experimental radiation nephropathy
The morphological expression of human radiation
nephropathy, as outlined above, represents the advanced
stages of the lesion, generally occurring when clinical
signs of radiation injury are present, about 6-18 months
after treatment. It has been amply demonstrated that the
glomerular lesion, so characteristic of the human disease, also predominates in experimental models, thereby
validating their use. Figures 6 and 7 demonstrate radiation nephropathy produced in mouse, rat, pig, and monkey. There is variable capillary loop thickening with
subendothelial expansion and basement membrane reduplication. The mesangium shows lysis of cells and matrix
in continuity with the subendothelial space. Capillary
loop collapse and mesangial sclerosis eventually develop.
These experimentally induced glomerular lesions appear
to develop regardless of the examined species (Table 1).
Sequential studies of experimental radiation nephropathy have revealed a variety of additional morphologic alterations to capillary loops and mesangium in the
542
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Figure 8 (at left) . Hyperchromatic enlarged nuclei (arrow) in a mouse glomerulus 7 months after irradiation with a
single dose of 19 Gy. Hematoxylin and eosin. Bar = 10 µm.
Figure 9 (at right). Nuclear enlargement (arrow) and a prominent lymphoid infiltrate (small dark nuclei; open arrow)
in a pig glomerulus, 4 weeks after irradiation with a single dose of 9.8 Gy. Periodic acid-Schiff. Bar = 10 µm.

------------------------------------ - - - - - - - - - - - - - - - Table 1. The morphologic features observed in the various components of the kidney following irradiation in different
species. Figures in parentheses refer to the time after irradiation at which these changes have been observed.
Species ...

Mouse

Rat

Dog

Pig

Monkey

Human

Glomerular features
nuclear enlargement
inflammation
mesangial proliferation
mesangiolysis/thrombosis
glomerulosclerosis

+ (2 weeks)
+ (2 weeks)
+ (6 weeks) + (6 months)
+ (10 months) + (2-3 months) + (2 months) + (3 months) + (6 months)
+ (10 months) + (2-3 months) + (3 months) + (5 months) + (6 months)

+(> 3 months)

+
+

Vascular features
thrombosis medial hyperplasia
intimal thickening

+ (3 months)

+ (4 months)
+
+ (2 months) + (3 months) + (6 months)
+ (6 months)

+
+

+ (2 weeks)

+ (4 months)

+

+ (2-3 months) + (2 months) + (3 months) + (4 months)

+

Tubular/interstitial features
reactive changes
tubulolys{~ months)
tubular atrophy/
interstitial fibrosis

+ (6 months)
+ (6 weeks)
+ (6 months)

+ (6 weeks)
+ (4 weeks)

initial phases of radiation injury. Both mice and pigs
show prominent nuclear enlargement in a subset of glomerular, presumably endothelial, cells [62, 64, 76, 110,
111, 154, 159] (Figs. 8 and 9). Infiltration of glomerular capillary loops by mononuclear cells, presumably
lymphoid in nature, consistently occurs in pigs [76, 154]

+ (6 weeks)

(Figs. 9 and 10). In addition, there are pronounced
changes in the mesangium. Diffuse and severe mesangial hypercellularity is observed in monkeys, but appears
to be more focal in pigs (Figs. 11-15). In our experience, there is little evidence of mesangial hypercellularity in mice or rats, although other studies have reported
543
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Figure 10. An electron micrograph showing a lymphocyte (arrow) adherent to a glomerular capillary endothelial cell (E). Pig, 9.8 Gy, 9 weeks PL Bar = 2 µm.
Figure 11. Global mesangial hypercellularity in monkey, 44 Gy, 45 weeks PL Hematoxylin and eosin. Bar

=

10 µm.

increased MC proliferation [110, 112]. However, all
species exhibit mesangial sclerosis.
Although prominent mesangial and endothelial alterations are observed consistently in radiation nephropathy, the podocytes appear less affected. Focal lms of
foot processes certainly develops. However, many glomeruli may show good retention of their foot processes

Figure 12.
Segmental mesangial hypercellularity
(arrow) in pig, 9.8 Gy, 4 weeks PI. Hematoxylin and
eosin. Bar = 12 µm.
Figure 13. Electron micrograph depicting mesangial
cell proliferation in pig, 9.8 Gy, 12 weeks PL Bar =
5 µm.

544
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Figure 14 (at left). Electron micrograph showing mesangial matrix (M) increase (i.e., mesangial sclerosis). Compare
with mesangiolysis seen in Figure 7 (C-capillary lumen). Pig, 9.8 Gy, 12 weeks PI. Bar = 2.5 µm.
Figure 15 (at right). Electron micrograph showing segmental collapse of capillary loops (arrow) and subendothelial
expansion (curved arrow). Pig, 9.8 Gy, 24 weeks PI. Bar = 2.5 µm.

-----------------------------------------------------------------------------(Fig. 16). Denudation or necrosis of podocytes is not
observed, even following capillary loop collapse or
complete glomerulosclerosis.
Both vascular and tubular interstitial injury contribute to the renal dysfunction clinically defined as radiation nephropathy (Table 1). The respective contribution
of these lesions and the role that irradiation plays in
their development impart an additional layer of complexity yet to be unraveled. It long has been recognized that
the morphologic parameter in the majority of human renal diseases most closely related to azotemia is tubulointerstitial disease [17, 52] . Although tubular atrophy
may be a primary event in many diseases, atrophy invariably ensues following glomerular sclerosis, regardless
of the initial insult. Furthermore, hypertension has been
shown to develop and presumably, to produce occlusive
vascular lesions in irradiated kidneys. Both glomerular
sclerosis and tubular atrophy can develop as a consequence of hypertension [193]. Therefore, it is unclear
to what extent radiation directly produces tubular or vascular injury, since each may develop for other reasons.
In early phases of radiation injury, small cortical
foci of reactive appearing tubular epithelium is seen.
These are characterized by nuclear enlargement, nuclear
predominance, and basophilic cytoplasm (Fig. 17). In

advanced stages, tubular atrophy develops, characterized
by small tubular cells enveloped by a thick, irregular
basement membrane, which, in our experience, does not
develop in the absence of significant glomerular alterations. A distinctive subcapsular accentuation of these
tubular alterations is prominent in pigs [154], and also
has been reported in humans [85]. Although its distribution corresponds to a vascular pattern, the basis for the
pattern is not clear.
A third distinctive form of tubular injury develops
in mice and rats; we have called this lesion tubulolysis.
Here, there is apparent lysis of tubular cells [81, 110],
leaving an empty or denuded profile of tubular basement
membrane (Figs. 18 and 19). These tubules lack the
thick, wrinkled basement membranes characteristic of
atrophic tubules. Tubulolysis has not been observed in
pigs or monkeys, nor has it been described in humans.
In contrast, interstitial fibrosis with mild interstitial
inflammation is a common feature of advanced disease
in all species.
Diverse vascular lesions develop in radiation nephropathy. In humans, both thrombotic lesions in arterioles (Fig. 4A) and arteries occur and intimal occlusive
vascular lesions of large arteries (Fig. 1) can develop.
Experimental animals demonstrate the same range of
545
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Pathogenesis

Studies on the pathogenesis of radiation nephropathy
have been plagued by controversy centered on the specific target cell(s) and pathophysiological mechanism(s)
involved in the development of this lesion. Arguments
have revolved around two opposing schools of thought
concerning the primary site of renal injury, namely, vascular versus parenchymal. Rubin and Casarett (162)
proposed that the principal lesion was arterionephrosclerosis, with extra-glomerular vascular injury leading to
vessel occlusion, ischemia, and secondary tubular atrophy and degeneration. However, arteriolar changes are
an uncommon feature of experimental and clinical radiation nephropathy [36) in the absence of systemic arterial
hypertension. Indeed, arteriolar lesions are less severe
as compared with tubular or glomerular lesions or may
even be absent [202). Thus, the classical hypothesis that
tubular degeneration occurs only secondary to injury of
the vasculature and thrombosis is no longer tenable.
Diametrically opposed to the vascular hypothesis is
the parenchymal hypothesis, proposed by Withers et al.
[203). Based upon observations of irradiated kidneys of
a specific strain of inbred mice, they concluded that radiation nephropathy results from tubule cell depletion
alone. This hypothesis, a bench-mark in radiation biology, served to stimulate a shift of emphasis from vascular
injury as the sine qua non to explain the pathogenesis of
late radiation injury per se. However, this hypothesis
ignores the wealth of data not only from experimental
studies involving a variety of species including other
murine strains [34, 62, 64, 129, 159), but also from
clinical studies involving localized [85, 86, 160, 161) or
TBI [9, 33, 73, 75, 188) that show glomerular damage
occurring either before or concomitantly with the development of tubular damage. Although it is certainly the
case that proximal tubule epithelial cells are radiosensitive, with cell loss being evident within several weeks of
irradiation, they are not the only target cells involved in
the development of radiation nephropathy. Thus, the
classical view that radiation nephropathy involves vascular or parenchymal cell loss alone is simplistic.
In recent years, the characteriz.ation of radiation-induced normal tissue morbidity has undergone a paradigmatic shift. Pathophysiological data from a variety of
late-responding normal tissues indicate that the expression of radiation-induced normal tissue injury involves
complex and dynamic interactions between several cell
types within a particular organ [76, 163, 170). These
cells are viewed now not as passive observers, merely
dying as they attempt to divide, but rather as active
participants in an orchestrated response to injury. The
central dogma of radiation biology, in which irradiation
causes damage to DNA, leading to death of the cell

Figure 16. Scanning electron micrographs of a pig glomerulus 24 weeks Pl 9.8 Gy, showing podocytes with
intact foot processes (arrow; P: podocytes cell body).
Bars = 10 µm (A) and 2.5 µm (B).

----------------------------------lesions, but show marked interspecies variation. Arteriolar and arterial thrombosis develops in parallel with
glomerular thrombosis in both rats and monkeys (Figs.
20 and 21), particularly at high radiation doses.
Thrombotic lesions are very rare in mice, even following high radiation doses, and have not been reported to
develop in pigs. Occlusive but non-thrombotic vascular
disease also develops in pigs, rabbits (166), dogs [125],
and monkeys, but differs in the arterial layer affected.
Pigs, rabbits, and dogs develop arteriolar and arterial
medial hyperplasia. In pigs, medial hyperplasia develops only in the unilateral irradiation model; it is not evident in the bilateral irradiation model (Fig. 22). In contrast, monkeys develop occlusive intimal thickening
without medial alterations (Fig. 23). However, rats and
mice have not been reported to develop either of these
chronic occlusive vascular lesions following kidney
irradiation.
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Figure 17. Deep cortical medullary ray of a pig showing reactive tubular epithelium, a cell in mitosis (arrow),
and interstitial edema. 9. 8 Gy , 6 weeks PL Periodic
acid-Schiff. Bar = 10 µm.
Figure 18. Tubulolysis (arrows) in mouse characterized
by total disappearance of tubular cells leaving naked tubular basement membranes. 15 Gy, 12 months PL Hematoxylin and eosin. Bar = 15 µm.
Figure 19. Electron micrograph of mouse kidney showing tubulolysis (arrows). 15 Gy, 12 months PL Bar =
10 µm.
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is now being directed to consider the radiation response
of the various cell types in terms not solely of survival,
but also of altered cellular behavior.
To fully understand the pathogenesis of radiation nephropathy, it is necessary to consider the response of,
not one, but several cell types. We propose that these
are primarily the glomerular capillary ECs and MCs,
and, albeit to a lesser extent, the proximal tubule epithelium. The morphologic and functional data presented in
this review suggest that glomerular capillary endothelial
cell damage represents an important primary event in renal radiation injury. Radiation-induced increases in the
labeling index of these cells occur within two weeks of
radiation [156], confirming that the microvascular ECs
appear to be the most radiosensitive of the vascular wall
components [146]. Although the direct effects of radiation on glomerular capillary EC function and/or functional changes resulting from cell loss remain ill-defined,

•

when it attempts to divide, now is seen as only one part
of the overall picture. Ionizing radiation appears to
cause a marked alteration in the phenotype of cells, due
to activation of transcription and signal transduction
pathways. Thus, in vitro, radiation has been shown to
activate early-response genes, such as c-jun, Egr-1,
c-fos, and NFKB (for review see [195]) via activation of
kinases including protein kinase C and tyrosine kinase.
The products of these early response genes may serve to
regulate downstream genes, such as cytokines and
growth factors that could play a role in cell and organ
response to radiation injury. The importance of this new
paradigmatic approach to radiation-induced morbidity,
and specifically, radiation nephropathy, is that research
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Figure 20. Arterial (arrow), arteriolar, and glomerular
thrombosis, segmental glomerular sclerosis, and severe
tubular atrophy (open arrow) in a mouse kidney. 19
Gy, 12 months PL Periodic acid-Schiff. Bar = 15 µm.

Figure 21. Arteriolar (arrow) and glomerular capillary
thrombosis (curved arrow) in a monkey kidney. 44 Gy,
45 weeks PL Periodic acid Schiff. Bar = 15 µm.
Figure 22. Pig kidney showing medial hyperplasia of
both arteries and arterioles (arrow) in the peripheral cortex associated with glomerulosclerosis (curved arrow)
and tubular atrophy. 9.8 Gy, 20 weeks PI. Periodic
acid-Schiff. Bar = 20 µm.
one of the earliest morphological changes appears to be
the attachment of leukocytes to the glomerular capillary
endothelium [76). Endothelial cells irradiated in vitro
release a chemotactic factor, which appears to be a lipid
product of the lipoxygenase pathway [49]. Furthermore,
irradiation has been shown to modulate EC/leukocyte interaction by causing a marked release of 13-hydroxyoctadecadienoic acid (13-HODE) [21], a chemorepellant
believed to act as an internal regulator influencing the
expression of adhesive molecules on the EC surface
[22]. Thus, radiation may cause increased production of
EC-derived chemoattractants, reduction in EC-derived
chemorepellants, and loss of down-regulation of the cell
adhesion surface, effectively promoting endothelial/leukocyte interaction. This event also may reflect a radiation-induced increase in the synthesis and/or upregulation of endothelial surface leukocyte adhesion molecules,
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such as E-selectin and ICAM-1 [173). Radiation-induced activation of adhesion molecules in vitro has been
reported following radiation of normal and malignant
glial cells and human cerebral microvascular ECs [207;
Brayton et al., unpublished observations]. Furthermore,
glomerular capillary ECs often appear swollen with the
appearance of increased metabolic activity at this time,
an appearance which is associated with endothelial activation [140).
In addition, radiation appears to cause a profound
increase in the permeability of the glomerular capillary
endothelium, as evidenced by both transudation and emigration of plasma and red blood cell components into the
subendothelial and mesangial compartments. These
events lead to marked pericapillary edema and reduction
in lumen cross-sectional diameter. It is of interest to
note that experimental [57, 76, 110) and clinical studies
[86) suggest that the podocytes appear relatively unaffected at this time; the minimal degree of proteinuria
found at these times is consistent with this observation.
These findings suggest radiation-induced glomerular EC
damage without either concomitant basement membrane
damage or altered permeability; irradiation of ECs in
vitro is associated with increased transendothelial movement of albumin [184). This subendothelial widening
also may represent loss of adhesive interaction between
the EC and the glomerular basement membrane via altered integrin expression. Integrins are a family of matrix receptors [2] that play an important role in cell-cell
and cell-matrix interaction in several systems, including
the kidney [1). lmmunoelectron microscopic studies of
human kidney have demonstrated increased density of {3 1
integrins on the portion of glomerular capillary EC facing the glomerular basement membrane [87). Furthermore, integrin antibodies alter EC permeability properties and their capacity to retain macromolecules [100).
Radiation might cause a loss of these receptors, with
subsequent loss of cell-cell adhesion and increased permeability, leading to marked widening of the subendothelial space. At present, such a proposal is purely
speculative, and requires experimental verification.
These alterations in glomerular EC permeability and
subendothelial transudation occur concomitantly with a
significant reduction in GFR [76), indicating a possible
causative relationship. However, the regulation of glomerular capillary hemodynamics and filtration is multifarious. Both glomerular ECs and MCs elaborate and
respond to a host of vasoactive factors important in regulating capillary hemodynamic and filtration properties.
These include prostacyclin (PGI2), nitric oxide, and endothelin [138). The mesangium, by virtue of its contractile properties, is intimately involved in the regulation of glomerular blood flow. As such, it responds directly or indirectly to circulating and locally synthesized

Figure 23.

Monkey kidney showing florid arterial
occlusive intimal thickening (arrow) without medial
alterations. 44 Gy, 23 weeks Pl. Hematoxylin and
eosin. Bar = 10 µm.

vasoactive substances such as angiotensin II (All), vasopressin, platelet activating factor (P AF), thromboxane
A2 (TXA2), and prostaglandin Bi by contraction, and results in reduced glomerular filtration surface area and ultrafiltration coefficient [167). In response to All and
vasopressin, mesangial cells also produce PGI2 , which
causes mesangial relaxation and may modulate contractility [187).
A radiation-induced reduction in PGI2 production
has been observed in vitro [3] and in vivo [172), possibly reflecting damage to the enzymatic machinery required for PGI2 production [50). Renal irradiation, as
either localized [196) or TBI [168) leads to excessive
levels of TXA2 , resulting in increased vasoconstriction.
Excess TXA2 production also will render the endothelium more thrombogenic. Thus, the microthrombi seen
in more severe radiation nephropathy may further reflect
radiation-induced perturbations in EC eicosanoid metabolism.
These initial, primarily EC alterations, are augmented at later times by a progressive mesangial involvement, evidenced by mesangial hyperplasia and/or
hypertrophy with increased matrix formation. This leads
to progressive obliteration of glomerular capillaries and
sclerosis, and appears to play a key role not only in radiation nephropathy, but also in other forms of chronic
renal injury [74, 90, 143]. Mesangial proliferation may
occur in response to a variety of growth factors and
cytokines released by injured or stimulated ECs, podocytes, and MCs themselves, as well as infiltrating cells
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and platelets [186]. Although there is, as yet, no information available regarding the effect of radiation on
MCs, irradiation has been shown in vitro to cause release of mitogens from ECs, including platelet-derived
growth factor and fibroblast growth factor-like substances [49). Renal irradiation also leads to tubular
damage. This may result from direct radiation-induced
cell kill, may in part be secondary to the initial glomerular injury, and may reflect the presence of significant
extraglomerular lesions.
Radiation, thus, damages both glomerular and tubular components. The resulting lesions will interact and
will further exacerbate the overall pathology. Associated with these changes will be the added complication
of late vascular damage, resulting in secondary ischemic
insult and the possible development of hypertension
[199). Moreover, the progressive nature of the glomerular lesion likely leads to hypertrophy and hyperfiltration
by the remaining nephrons. Both processes have been
reported to cause additional glomerular injury [6, 54).
The kidney becomes locked in a pathogenic circle of increasing nephron loss and damage, the end results of
which are destruction of the renal parenchyma, glomerulosclerosis, and ultimate renal failure.
In summary, although the specific pathogenic mechanisms involved remain to be defined, the classic view
that radiation nephropathy involves either vascular or
parenchymal cell loss alone is clearly oversimplistic.
The renal response to irradiation is essentially identical
to that observed in a number of chronic progressive
nephropathies; no pathognomonic characteristics can be
identified in the irradiated kidney . The resultant clinical
expression of damage in the kidney involves complex
and dynamic interactions between the various cell types.
The lesion appears to be predominantly glomerular in
nature.
What direction does research in this area need to
take? Clearly normal renal function is the result of precise and complex interactions between the various cell
types. Specific biomolecules produced by the cells regulate cellular interaction and function via paracrine and
autocrine mechanisms, ensuring the maintenance of
function in the face of alterations to the cellular environment. Irradiation leads to both cell loss and injury. In
the past, studies of radiation nephropathy, and indeed renal disease per se, were limited to various pharmacological mechanisms of injury, combined with assessment of
the histologic and physiological consequences. Advances in molecular biology over the last few years have
opened up an exciting new avenue of research in renal
pathophysiology. Cellular injury leads to alterations in
gene expression, e.g., upregulation of genes regulating
repair and regeneration. Techniques are now available
to investigate the location, structure, activity, regulation

of production, and mechanism of action of these gene
products [132). Activated genes can be identified by the
presence of increased messenger RNA and their specific
protein products. The application of these powerful
techniques to probe radiation-induced alterations in glomerular capillary EC and MC function is likely to provide significant insight into the pathogenic mechanism(s)
involved in the development of radiation nephropathy.
Such mechanistic data will provide clues to developing
rational interventional procedures for the successful
amelioration of clinical radiation nephropathy.

Influence of Dose Fractionation on the
Radiation Tolerance of the Kidney
Clinically, the kidney is viewed as a radiosensitive
organ, a total dose of 20 Gy being considered the upper
limit of radiation "tolerance" [95). This dose has been
adopted somewhat arbitrarily, having been applied over
a broad range of dose fractionation schedules. Experimental studies have indicated that the kidney has an extensive capacity for repair of sublethal radiation damage;
the size of the dose of fractionated radiation markedly
influences the total tolerance dose [61, 68, 151, 179,
180, 201]. There is a marked increase in the tolerance
dose with decreasing size of the dose per fraction.
Renal fractionation data can be analyzed using the LQ
formula [44, 56):

E

= n(ad + fJd2)

(1)

where the effect (E) is a linear and quadratic function of
the dose per fraction ( d) and a function of the fraction
number (n) . This equation allows determination of the
a/fl ratio, a direct measure of the extent of curvature or
elasticity of the underlying cell survival curve. Generally, experimental kidney fractionation data have been well
described by the LQ model, with most studies indicating
an a/fl ratio of2-3 Gy [81, 179, 180, 190, 201), a value
typical of a late responding normal tissue. However, a
value of around 5 has been reported in the irradiated
mouse kidney , determined in terms of surviving tubule
cells assessed 19 months after irradiation [77).
At doses of < 1-2 Gy per fraction, major deviations
from the renal tolerance values predicted by the LQ
model were noted [180). This, in part, may reflect incomplete repair of sublethal damage between fractions,
since short interfraction intervals of 5 hours were used.
However, a reduction in repair capacity after multiple
irradiations, due to diminished induction of molecular
repair mechanisms [78) or the presence of a small population of radiosensitive cells, cannot be excluded.

Reirradiation and residual injury
The recurrence of a primary tumor or metastatic
spread might necessitate the re-irradiation or retreatment
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research in this area.
Although the successful protection of the irradiated
kidney with renal arterial infusion of adrenaline has been
reported clinically [175], the invasive nature of the technique precludes extensive use of such a procedure. Steroids have been reported to provide some symptomatic
help [169], but did not appear to modify the progressive
renal insufficiency. Although initial experimental data
indicated that such treatment potentiated radiation effects
on the renal vasculature [13, 25], this is now thought to
reflect the high doses of steroids which were employed.
More recent studies, using more appropriate doses, have
shown significant attenuation of functional and morphologic parameters of radiation nephropathy in the rat and
thus, have been associated with a significant increase in
long-term survival [58, 59]. Placing the patient on a
low protein diet may be helpful [114, 162]. A scientific
rationale for the clinical use of low protein diets has
come from recent studies on the consequences of reduced nephron number. This will lead to compensatory
glomerular hypertrophy and/or hyperfiltration in the
remaining nephrons that lead to further progressive glomerulosclerosis [20]. Low protein diets, which prevent
or at least attenuate this compensatory response, have
proven experimentally successful in reducing the severity
of progressive glomerular injury [69]. Dietary protein
restriction indeed can ameliorate the severity of radiation
nephropathy in the rat [112, 113] and pig [155]. However, it remains to be determined whether such an interventional procedure will offer the prospect of significant
clinical benefit.
Ongoing research into the pathogenesis and modulation of renal injury has provided exciting mechanistic insights into the renal response to injury. These advances
have allowed researchers both to reevaluate their hypotheses regarding the pathogenesis of radiation nephropathy
and to propose novel approaches to the future treatment
of radiation nephropathy.

of a previously irradiated volume, which included the
kidney. It has been suggested that renal reirradiation
can be considered, since parenchymal cell depletion was
negated by the repopulation of the tubules by surviving
clonogens [203] . However, experimental studies refute
thishypothesis[153, 158,178,181,182,183]. Studies
of retreatment tolerance in the kidney indicate the virtual
absence of any long-term recovery . Retreatment of the
kidney appears to add to a slowly developing initial lesion, causing a more rapid expression of previously subclinical injury. This occurs despite apparent evidence
for tubular regeneration [137, 154]. This tubular regeneration might be insufficient to match the rate of cell
loss following irradiation. In addition, tubular proliferation might occur without a corresponding organization
into functionally patent nephrons [182]. The lack of
recovery also may reflect the predominant role of the
glomerulus in the development of radiation nephropathy.
As discussed above, the glomerular lesions observed
following radiation are progressive, with no evidence of
recovery.
All these hypotheses require further experimental
investigations before definite conclusions can be drawn.
One should note that, whatever the underlying mechanisms involved, the kidney fail s to exhibit complete
Jong-term recovery of function following irradiation.
Thus, reirradiation of the kidney in patients should be
undertaken with extreme caution, if not avoided altogether.

Treabnent of Radiation Nephropathy
The incidence and severity of radiation nephropathy
obviously can be reduced by limiting the volume of renal
tissue irradiated and/or the amount of total dose administered. Indeed, renal shielding has successfully reduced
the incidence of renal dysfunction in BMT patients
receiving TBI [102]. However, any reduction in total
radiotherapeutic dose clinically employed carries with it
the risk of compromising tumor cell kill . An alternative
approach utilizes the application of interventional procedures directed at a selective reduction in radiationinduced renal morbidity. This approach, if successful,
will increase the threshold dose for radiation nephropathy and result in a clinically significant increase in therapeutic gain. Until recently, all chronic radiation-induced
normal tissue morbidity was viewed to be progressive
and essentially untreatable. However, the characterization of radiation-induced normal tissue injury has undergone a paradigmatic shift. The increasing awareness
that such morbidity is not simply a consequence of a
reduction in cell number of a particular target cell population, but rather the result of complex and dynamic
interactions between particular cell types, has stimulated

The Renin angiotensin system (RAS) Arruda [10]
first suggested that irradiation-induced damage to the renal vasculature led to renal ischemia, renin release, increased All production, and hypertension. As discussed
above, the lack of significant vascular injury occurring
as a primary event in radiation nephropathy led to a revision of this hypothesis. Thus, Robbins and Hopewell
[147] hypothesized that radiation caused a relative renal
cortical ischemia, which appeared to be mediated via the
RAS; the angiotensin-converting enzyme inhibitor
(ACEI) captopril abrogated the early radiation-induced
decreases in GFR and ERPF in the pig. However, later
studies failed to demonstrate a radiation-induced increased in plasma renin levels [80, 149]; the role of the
RAS in radiation nephropathy appeared to be minimal.
This negative conclusion was reached in view of the
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dogma regarding the RAS; renin is produced and stored
in the kidney and is released into the blood where AI is
generated, and the latter is converted to AIi by ACE
present in the pulmonary vasculature. However, renin,
AI, and AIi now have all been identified in the juxtaglomerular cells [72]. Moreover, angiotensinogen has been
detected as both mRNA and active protein in the rat kidney [26, 122] indicating the likelihood of intrarenal production of AIi. Thus, localized production of AIi may
occur independently of changes in circulating renin.
Evidence supporting this active involvement of AIi in
the pathogenesis of radiation nephropathy has come from
more recent studies using the ACEI captopril. This
compound has proven to be remarkably effective in the
treatment of a variety of chronic experimental [7, 15,
197] and clinicalnephropathies [70,104, 141]. Clearly,
captopril can reduce the severity of radiation nephropathy arising from both localized kidney irradiation [24,
32, 147] and TBI [126]. However, its mode of action
is unresolved. Studies with other non-thiol ACE inhibitors have indicated that the thiol group of captopril is not
essential for its renal action [83, 127]. Thus, its beneficial action appears to involve inhibition of All production. It should be noted that some of the beneficial actions of ACEI could reflect accumulation ofkinins, since
the ACEI is also kininase II. The advent of a new class
of orally active All receptor blockers has allowed the
role of AIi in renal disease to be further delineated [99,
205]. Determining the therapeutic efficacy of such
agents in the treatment of radiation nephropathy is
eagerly awaited.
Possible mechanisms to explain the efficacy of cap
topril have centered on the drug acting primarily to
block the hypertensive action [7] and/or the trophic action of Agll [54, 55]. In addition to its role in modulating renal hemodynamics, it has become apparent that
AIi plays an equally important role in the regulation of
renal cell growth. AIi can be considered to be a renal
cytokine, binding to specific cell surface receptors,
activating several signal transduction pathways associated
with cell growth, and inducing cell proliferation [131,
204]. In view of the central role of mesangial sclerosis
in radiation nephropathy, it should be noted that AIi
effects on mesangial cells include mesangial cell hypertrophy and hyperplasia [131, 204], upregulation of extracellular matrix genes [164], activation of early growth
genes [128], and generation of inflammatory mediators
and other growth factors [164]. These observations,
although speculative, appear to indicate a major role for
AIi in the pathogenesis of radiation nephropathy, thereby
warranting further study.

Transforming growth factor {J Any specific actions of AIi in the irradiated kidney would likely be
modulated via dynamic interactions with other renal

cytokines. Again, although there are few data yet available from models of radiation nephropathy, particular
growth factors appear very interesting. The role of
transforming growth factor beta (TGF-,B) in increased
mesangial matrix production is well documented [133,
206]. The successful blocking of renal TGF-,B activity
using antibodies [18] or the proteoglycan decorin [19],
a natural regulator of TGF-,B, results in suppression of
renal injury. A similar strategy may be of potential use
in radiation nephropathy. It is interesting to note that
the beneficial effect of dietary protein restriction in
reducing the severity of radiation nephropathy [112,
113, 155] can be explained, in part, by the ability of
protein restriction to downregulate TGF-,B expression,
thereby preventing increased glomerular extracellular
matrix production [134]. Although there are no data as
yet to show increased production of TGF-,B in the irradiated kidney, abnormal radiation-induced TGF-/3 production has been causally linked to the development of
radiation fibrosis in the skin [27, 116], lung [163], and
liver [8]. Irradiation of mesangial cells in vitro does
appear to cause upregulation of mRNA TGF-,B production (Robbins, unpublished observations). The recent
finding that AIi induces the synthesis of TGF-,B in
smooth muscle cells in vitro [164] suggests that irradiation-induced changes in MC activity may reflect an
ongoing interaction between All and TGF-/j.

Antioxidant enzymes Advances in understanding
the role of renal antioxidant enzymes in the pathogenesis
of reactive oxygen species (ROS)-induced renal injury
suggest that the therapeutic benefit of corticosteroids in
models of ROS injury may reflect, in part, a corticosteroid-induced upregulation of glomerular antioxidant
enzymes [71, 208]. A potential role for ROS in the
- pathogenesis of radiation nephropathy is suggested by
the presence in the irradiated kidney of mesangiolysis,
a lesion observed in ROS models of renal injury [185].
A corticosteroid-induced upregulation of antioxidant enzymes would provide a rationale for the reported benefit
of this therapy in attenuating radiation nephropathy in
the rat [54, 55].
Thus, there are a number of potential interventional
therapies that could prove to be beneficial in the treatment of radiation nephropathy. Further research is
needed to establish whether any of these will prove ultimately to be clinically applicable. At present, patients
presenting chronic radiation nephropathy and hypertension should be treated aggressively with antihypertensives; low protein diets may be useful in preventing glomerular hyperfiltration and hypertrophy. Renal dialysis
or transplantation may be practicable in a patient with
severe bilateral involvement. In general, the irradiated
kidney should be managed by a reduction in its functional load. It may well be that the function in all irradiated
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kidneys is compromised to varying degrees. Exposure
of the irradiated kidney to any additional nephrotoxic
insult should be viewed with extreme caution.
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tion than the ordinary 1. 8-2 Gy per fraction per day is
applied. Can the uncertainty regarding the relative
importance of glomerular/vascular and tubular effects be
due to differences in fractionation? Is there any indication from your data or literature that hyperfractionation
(smaller doses per fraction) can reduce the nephropathy
problem?
Authors: We would argue that there is little uncertainty
regarding the primary site renal injury in the irradiated
kidney. The data presented in this review clearly demonstrate that the lesion is primarily glomerular in nature.
There is no data to suggest that altering the fractionation
response has any significant effect in terms of altering
the pattern of the functional or morphological changes
seen in the irradiated kidney. While hyperfractionation
clearly results in significant sparing of the kidney, due
to its extensive capacity to repair sublethal injury, such
regimens still lead to the development of radiation
nephropathy in some BMT patients. The kidney remains
a significant dose-limiting normal tissue in radiotherapy.

V.H. Gattone: Total body irradiation (TBI) has become
prominent in the clinical setting of bone marrow transplant. Based on your review of the literature, would
you expect to see more favorable or detrimental renal
picture after TBI in pediatric patients, especially young
patients?
Authors: It is unlikely that a more favorable renal picture would be seen after TBI in pediatric patients. On
the other hand, the clinical evidence for the presence of
an age-effect with regard to increased susceptibility to
renal injury following TBI remains equivocal. Although
the best descriptions of TEI-induced nephropathy concern pediatric populations [9, 188], this might reflect
closer follow up of these patients, rather than increased
susceptibility of the growing kidney. Other studies have
failed to show an age-effect; Lonnerholm et al. [105]
reported renal dysfunction in 4/22 autografted children
(18%) compared with 8/50 (16%) adults. Several features of radiation nephropathy suggest a careful evaluation of renal function in the young patient after TBI.
The lesion is chronic, loss of renal function appears progressive, there is little significant long-term recovery of
function. Improvements in cancer therapy and enhanced
long-term survival of pediatric TBI patients reinforce the
need for such data. Any additional nephrotoxic insult
following TBI should be avoided if possible.

Discussion with Reviewers

A.P. Evans: What types of studies should be performed
to better understand the mechanisms of radiation injury
in the kidney? In other words, what clinical or experimental information is lacking concerning the mechanisms of radiation injury?
Authors: Although the predominant role of the glomerular capillary endothelial cell and the mesangial cell has
clearly been recognized, there is essentially no information available regarding the cellular response of these
cells to irradiation. Studies need to be directed at probing radiation-induced alternations in gene expression by
the use of molecular biology techniques using both in
vitro and in vivo techniques. Such mechanistic data will
allow the development of interventional procedures
directed at ameliorating the severity of radiation
nephropathy.
J.B. Reitan: Different cell types react differently to
fractionation of radiation dose in radiotherapy, and tissue
interaction of cell types is often overlooked in radiation
pathogenesis. The appearance of radiation nephropathy
may be another than the "classic" if different fractiona-
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